Chinese Second Hip Fracture Evaluation

Launched by BEIJING JISHUITAN HOSPITAL · Mar 5, 2018

Keywords

ClinConnect Summary

This clinical trial, called the Chinese Second Hip Fracture Evaluation, is studying people who have had a hip fracture due to osteoporosis, a condition that weakens bones. The main goal is to understand how often people experience a second hip fracture and to see how a first hip fracture affects bone strength, bone structure, and muscle around the hip using a special type of scan called quantitative computed tomography (QCT). The study also aims to find out if analyzing these scans can help predict the risk of having another hip fracture, and to explore differences between two common types of hip fractures.

People who might be eligible to join are those aged 47 or older who have osteoporosis and have had a hip fracture that was treated with surgery. Participants will need to agree to take part and sign a consent form. Those with certain conditions, like fractures caused by cancer, injuries from violence, or those with hip replacements on both sides, will not be able to join. If you participate, you can expect to have detailed imaging tests to measure your bone and muscle health, which will help doctors better understand your risk of another hip fracture and how to improve care for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • a:Osteoporotic patients b:Osteoporotic hip fracture patients (femoral neck fracture and femoral trochanteric fracture) c: Be willing to and be able to join in the study and sighed the informed consent
• Exclusion Criteria:
• • a:Under 47years old b:Non-surgical repair of hip fracture c:Pathologic fracture d:Violence-related trauma e:Bilateral hip implants or have hip replacement on the non-fractured side